Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

86% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (12)
P 4 (1)

Trial Status

Completed6
Not Yet Recruiting2
Recruiting2
Unknown2
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
Showing all 13 trials

Research Network

Activity Timeline